Graham K A, Reaich D, Goodship T H
Department of Medicine, University of Newcastle upon Tyne, England, United Kingdom.
Kidney Int Suppl. 1994 Dec;48:S47-50.
To prevent increased protein degradation and renal bone disease, optimal correction of acidosis should therefore be a priority in the management of CAPD patients. Initial results suggest that bicarbonate solutions may be more biocompatible than lactate, and one would expect increasing use over the next decade. Manufacturers could help to improve acid-base regulation in CAPD by providing a range of solutions with varying lactate and bicarbonate concentration, so that correction of acidosis could be optimized individually.